Franco Valle
Director Financiero/CFO en BIOMEA FUSION, INC. .
Fortuna: 267 435 $ al 30/04/2024
Cargos activos de Franco Valle
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIOMEA FUSION, INC. | Comptroller/Controller/Auditor | 26/07/2021 | - |
| Director Financiero/CFO | 26/07/2021 | - |
Historial de carrera de Franco Valle
Antiguos cargos conocidos de Franco Valle.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| EIDOS THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/01/2020 | 01/04/2021 |
| Director Financiero/CFO | 01/01/2020 | 01/04/2021 | |
| Corporate Officer/Principal | 01/03/2018 | 01/01/2020 | |
| IOVANCE BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/07/2016 | 01/01/2018 |
| Director Financiero/CFO | 26/07/2017 | 14/08/2017 | |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Comptroller/Controller/Auditor | 01/01/2012 | 01/05/2015 |
| PHARMACYCLICS, INC. | Comptroller/Controller/Auditor | - | - |
| LENZ THERAPEUTICS, INC. | Director Financiero/CFO | - | - |
Formación de Franco Valle.
| San Jose State University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Comptroller/Controller/Auditor | 5 |
| Director of Finance/CFO | 4 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| BIOMEA FUSION, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Eidos Therapeutics, Inc.
 Eidos Therapeutics, Inc. BiotechnologyHealth Technology Eidos Therapeutics, Inc. focuses on addressing the large and growing unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). Its product include the AG10, an orally-administered small molecule designed to potently stabilize TTR, suggesting a treatment with the potential to halt the progression of ATTR. The company was founded by Graef Isabella and Alhamadsheh Mamoun on August 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Pharmacyclics, Inc. develops drugs to treat cancer. The private company is based in Sunnyvale, CA. Robert William Duggan has been the CEO of the company since 2015. | Health Technology |
- Bolsa de valores
- Insiders
- Franco Valle
- Experiencia
